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ABSTRACT
Introduction: Chronic obstructive pulmonary disease
(COPD) represents an important public health
challenge. Patients are confronted with limitations
during activities of daily living (ADLs). Resident loved
ones of patients with COPD may be uniquely
positioned to witness these limitations. COPD may
have an impact on not only the patients’ life, but also
on the lives of the resident loved ones. Furthermore,
COPD exacerbation-related hospital admissions often
occur in patients with COPD. However, whether and to
what extent these admissions influence resident loved
ones’ burden and health status remains currently
unknown. Therefore, the primary objectives of this
study are to investigate the differences between
patients with COPD and resident loved ones’
perceptions of patients’ health status and problematic
ADLs and to study prospectively the effects of a COPD
exacerbation on resident loved ones’ perceptions of
patients’ health status and problematic ADLs.
Methods and analysis: An observational,
longitudinal study will be performed in 192 patients
with COPD and their 192 resident loved ones. Primary
outcomes are daily functioning, ADL, disease-specific
health status, generic health status and dyspnoea.
These will be assessed during home visits at baseline
and after 12 months. Additional home visits will be
performed when a COPD exacerbation-related hospital
admission occurs during the 12-month follow-up
period.
Ethics and dissemination: This protocol was
approved by the Medical Ethics Committee of the
Catharina Hospital Eindhoven, the Netherlands
(NL42721.060.12/M12-1280) and is registered in the
Dutch Trial Register (NTR3941).
INTRODUCTION
Chronic obstructive pulmonary disease
(COPD) is the fourth cause of death in the
world1 and represents an important public
health challenge.2 Owing to continued
exposure to COPD risk factors and aging of
the population, the burden of COPD will
increase in the upcoming decades.2 This,
combined with the shortage in healthcare
stafﬁng3 most probably causes a shift towards
home care.
Commonly, patients with COPD suffer
from multiple symptoms, like dyspnoea,
coughing, sputum production, fatigue,
anxiety and/or depression.4 Therefore, it is
not very surprising that patients with COPD
experience symptoms during activities of
daily living (ADLs).5 6 Resident loved ones
may be uniquely positioned to witness the
limitations that patients with COPD experi-
ence during (physical and instrumental)
ADLs.
The terminology used to refer to the care-
giver role is ambiguous.7 The terms ‘family
caregiver’ or ‘informal caregiver’ refer to a
person, often a family member or friend,
who is providing care, but is not a healthcare
professional.8 9 However, informal caregivers
Strengths and limitations of this study
▪ This study contains an individualised, client-
centred outcome measure with a semistructured
interview method (the Canadian Occupational
Performance Measure) to assess activities of
daily living (ADLs).
▪ The longitudinal design of the present study will
allow studying the problematic ADLs after 1-year
follow-up, but also 2 weeks after a chronic
obstructive pulmonary disease exacerbation-
related hospital admission.
▪ Recruitment of participants with an equal distrib-
uting concerning sex and disease severity will be
challenging.
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themselves, in particular spouses, do not refer to the
notion of being a caregiver, often describing it as an
extension of their loving role and commitment to the
person requiring support.10 11 Therefore, in this study,
the term resident loved one will be used. We adopt the
following deﬁnition: a person living together with a
patient with COPD, regardless of whether they provide
care to the patient with COPD.
Caring for a loved one with advanced COPD is
described as a full-time role that is akin to that of caring
for people with severe disability.12 General day-to-day
commitments of resident loved ones are planned
around the care of the patient with COPD.13 Therefore,
caregiver burden is common in family caregivers of
patients with COPD.13 14 However, caregiver burden is
not associated with objective measures of the patient’s
need for assistance.13 In fact, caregiver burden seems
more associated with the loved ones’ report of need for
greater help13 and symptoms of depression of the
patient.14 It is known that discrepancies exist in spouses’
perceptions of patients’ symptoms and health status and
those of the patients themselves.15 16 How resident loved
ones interact with patients with COPD probably depends
on many determinants, such as their perceptions of
patients’ limitations in ADLs, the quality of the relation-
ship, as well as the patients’ health status and mood
status.14 17 On the other hand, spouses' anxiousness is a
predictor for the health status of patients with COPD.18
Family caregiving is most probably a dynamic process,
in which an escalation in loved ones’ anxiety, depression
and psychological distress may occur as the patient’s
functional status declines over time or during a hospital-
isation due to a COPD exacerbation.17 19 20 In fact, care-
givers of patients with heart failure who had fewer
emergency department visits felt more positive about
caregiving than other caregivers.21 Whether and to what
extent COPD exacerbation-related hospital admissions
inﬂuence resident loved ones’ burden and health status
remains currently unknown.
Objectives of the study
The primary objective of this study in patients with
COPD is twofold:
1.1 To investigate the differences between patients with
COPD and resident loved ones’ perceptions of
patients’ health status and problematic ADLs.
1.2 To study prospectively the effects of a COPD exacer-
bation on resident loved ones’ perceptions of
patients’ health status and problematic ADLs.
Furthermore, the following secondary objectives will be
addressed:
2.1 To investigate the differences between patients with
COPD and resident loved ones’ perceptions of
patients’ mood status, care dependency and daily
symptoms.
2.2 To investigate the general well-being of patients when
discrepancies exist between the patients’ and resident
loved ones’ perceptions of patients’ care dependency.
2.3 To investigate if general well-being of patients and
loved ones is inﬂuenced by the health or mood
status of the signiﬁcant other.
2.4 To study the relationship between lifestyle factors
(like physical activity, smoking habit and fat free
mass) in patients with COPD and their resident
loved ones.
2.5 To investigate resident loved ones’ burden due to
patients care dependency.
2.6 To investigate resident loved ones’ knowledge about
COPD and the relationship with anxiety and social
support.
3.1 To study prospectively the effects of a COPD exacer-
bation on resident loved ones’ perceptions of
patients’ mood status, care dependency and daily
symptoms.
3.2 To investigate whether and to what extent loved
ones’ burden and resident loved ones’ health and
mood status are inﬂuenced by exacerbation-related
hospital admissions.
4.1 To capture differences at baseline and 12 months
later between patients’ and resident loved ones’ per-
ceptions of patients’ health status, problematic
ADLs, mood status, care dependency and daily
symptoms.
The objective of this article is to show the rationale
and methods of this observational, longitudinal study in
patients with COPD and their resident loved ones.
Furthermore, this detailed description of the research
protocol of the Home Sweet Home study will serve as refer-
ence for the method section of future publications of
this study. Finally, the current manuscript provides an
outline of the possible strengths, weaknesses and clinical
consequences.
METHODS AND ANALYSIS
Study design
An observational, longitudinal study on the home envir-
onment of people with COPD has been designed. All
data will be collected during home visits at baseline and
after 12 months. Additional home visits will be per-
formed when an exacerbation-related hospital admission
occurs during the 12-month follow-up period. The resi-
dent loved one will be visited extra at home <7 days after
admission of the patient with COPD to the hospital.
Finally, 2 weeks after discharge, the patient and loved
one will be visited once more at home. Figure 1 gives a
complete overview of the study design. Data collection
will take place from July 2013 until April 2016.
Eligibility criteria
Eligible patients are those who satisfy all of the following
criteria:
1. Patients with moderate to very severe COPD as main
diagnosis (Global initiative for chronic Obstructive
Lung Disease (GOLD) grade II, III or IV);22
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2. No exacerbation of COPD (deﬁned as ‘an acute event
characterised by a worsening of the patient’s respiratory
symptoms ie, beyond the normal day-to-day variations and
leads to a change in medication’)23 or hospitalisation
<4 weeks preceding enrolment;
3. Provided written informed consent;
4. One resident loved one (deﬁned as a person living
together with a patient with COPD, regardless of
whether they provide care to the patient with COPD)
also provided written informed consent to
participate.
Patients will be excluded if:
1. Patient and/or resident loved one is unable to complete
the study questionnaires because of cognitive impairment
(deﬁned as Short Blessed Test score ≥10 point);24 25
2. Patient and/or resident loved one is unable to speak
or understand Dutch.
Patients will be equally divided based on gender and
GOLD grade. Furthermore, about two-third of the par-
ticipating patients should be frequent exacerbators
(deﬁned as two or more COPD exacerbations,26 or one
or more COPD exacerbation-related hospital admission
in the year before baseline measurements).27
From eligible non-participating patients, some data
like disease severity (GOLD grade), gender, and age will
be collected to compare characteristics of participating
and non-participating patients.
Outcomes
The following primary outcomes will be assessed at the
patients’ home environment: Daily functioning (Canadian
Occupational Performance Measure (COPM)28 and the
Instrumental Activities of Daily Living Scale (IADLS));29
disease-speciﬁc health status (COPD Assessment Test
(CAT));30 generic health status (12-Item Short Form
Health Survey (SF-12),31 and the EuroQol 5-Dimensions
(EQ-5D));32 Dyspnoea (modiﬁed Medical Research
Council (mMRC) dyspnoea scale).33
In addition, the following secondary outcomes will be
assessed: Symptoms of fatigue (Subjective Fatigue subscale
of the Checklist Individual Strength (CIS));34 exercise self-
efﬁcacy (self-efﬁcacy for home walking questionnaire);
symptoms of anxiety and depression (Hospital Anxiety and
Depression scale (HADS));35 general well-being
(Assessment of Quality of Life with 8 dimensions
(AQoL-8D));36 mobility (Timed-Up-and-Go test);37 daily
symptoms using visual analogue scales (VAS);4
COPD-speciﬁc knowledge (CIROPD knowledge question-
naire); coping (Utrecht Coping List (UCL));38 care
dependency (Care Dependency Scale (CDS),39 and infor-
mal and professional care <6 months);4 physical activity
and motivation (validated accelerometer,40 the Behavioural
Regulation in Exercise Questionnaire (BREQ-2),41 and the
social-individual focus); smoking status (self-developed
questionnaire, and the Fagerström test for nicotine
dependence);42 social support (Medical Outcome Study
Social Support Survey (MOSSSS));43 quality of the relation-
ship (Dutch relationship questionnaire (NRV));44 cognitive
functioning (Short Blessed Test (SBT));24 caregiver
burden and positive aspects of caregiving (Family Appraisal
of Caregiving Questionnaire for Palliative Care
(FACQ-PC)45 (only for resident loved ones)); clinical
characteristics (fat-free mass (using body impedance assess-
ment (BIA)),46 body weight and height, post-
bronchodilator spirometry, resting blood pressure, resting
heart rate and resting transcutaneous oxygen saturation).
Additionally, demographics (such as age, gender,
marital status and working status), medical history,
(Charlson comorbidity index),47 current medication
and home adaptations and aids4 will be recorded.
The resident loved one will be asked to contact the
study team when an exacerbation-related hospital admis-
sion occurs during the 12-month follow-up period.
Furthermore, COPD exacerbation-related hospital
admissions of participants will be checked weekly in the
participating hospitals by the study team.
Figure 1 Timing of the home
visits. Home visits will take place
in all patients and their loved
ones at baseline and after 1-year
follow-up. Additional home visits
will be planned when a chronic
obstructive pulmonary disease
exacerbation-related hospital
admission occurs.
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Besides questionnaires that will be administered about
the patient or the resident loved one themselves, resi-
dents loved ones will be asked to complete question-
naires regarding their perception of the health status or
situation of the patient. Table 1 provides an overview of
the measurements per time point.
Questionnaires that were not available in Dutch have
been translated into Dutch by the procedure of forward-
backward translation.
Sample size
Since no preliminary data are available concerning differ-
ences in perception in health status and ADLs, the sample
size for the primary objective 1.1 is estimated using G
power. A total of 171 patients and 171 resident loved ones
are needed to detect an effect size of 0.25 with a signiﬁ-
cance of 5% and power of 90%. Since we expect about
10% dropout, 10% additional couples will be included.
Furthermore, patients will be equally divided based on
gender and GOLD grade. Therefore, the study population
consists of 192 patients and their resident loved ones.
For objective 1.2, 38 patients with an exacerbation-
related hospital admission during follow-up are needed
to detect a medium effect size of 0.5 (signiﬁcance 5%
and power 85%). In this study sample, we expect about
46 hospital admissions.48 Therefore, a sample size of 192
patients and 192 loved ones will also be sufﬁcient to
answer objective 1.2.
Table 1 Overview of measurements per home visit
Baseline
Hospital
admission
Hospital
discharge
1-year
follow-up
P
LO’s
perc. LO P
LO’s
perc. LO P
LO’s
perc. LO P
LO’s
perc. LO
Fat-free mass/height/weight x x x x x x
Physical activity monitor x x x x x x x
Post-bronchodilator spirometry x x x x x
Blood pressure/heart rate/saturation x x x x x x x
Timed-up-and-go test x x x x x x x
Cognitive test (Short Blessed Test) x x x x x
Problematic activities of daily living, Canadian
Occupational Performance Measure (COPM)
x x x x x x
Background information x x x x
Smoking history and habits x x x x x x
Fagerström test for nicotine dependence x x x x x x
COPD Assessement Test (CAT) x x x x x x x
mMRC dyspnoea scale x x x x x x x
Hospital Anxiety Depression Scale (HADS) x x x x x x x x x x x
12-Item Short Form Health Survey (SF-12) x x x x x x x
Informal and professional medical care <6 months x x x x x x x
Checklist home adaptations and aids x x
Care Dependency Scale (CDS) x x x x x x x x x x x
Instrumental Activities of Daily Living scale
(IADLS)
x x x x x x
Daily symptom checklist x x x x x x x
EuroQol 5D (EQ-5D) x x x x x x x x x x x
Medical Outcomes Study Social Support Survey
(MOSSSS)
x x x x x x x
Charlson comorbidity index x x x x x x
Subjective fatigue scale (CIS) x x x x x x x
COPD knowledge questionnaire (CIROPD) x x x x x x
Coping style (UCL) x x
Self-efficacy for home walking x x x x x x
Dutch relationship questionnaire (NRV) x x
Behavioural Regulation in Exercise Questionnaire
(BREQ-2)
x x x x x x
Social-individual focus x x x x x x
Assessment of Quality of Life with 8 dimensions
(AQOL-8D)
x x x x x x x x x x x
Family Appraisal of Caregiving Questionnaire for
Palliative Care (FACQ-PC)
x x x x
LO’s perc., loved one’s perception of the person with COPD; LO, loved one; P, patient.
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Recruitment
Patients, both with and without COPD exacerbations in
the past year, will be recruited by their chest physician
or a respiratory nurse during hospital admission or at
the outpatient clinic in four hospitals throughout the
southern-eastern part of the Netherlands. In addition,
patients participating in the study ‘Correlates of CAT’
(NTR3416) who meet the inclusion criteria of the Home
Sweet Home study and were willing to participate in
further research will be asked to participate in the
current study. If patients and their loved ones agree, an
appointment for a ﬁrst home visit will be made.
Informed consent will be obtained at the start of this
visit.
Data management and statistical analysis
Missing data will be minimised because all question-
naires will be completed in the presence of a researcher
or research assistant. Handling of missing data will be
carried out according to the guidelines of the different
questionnaires. For data-analysis SPSS V.20.0 will be
used.
Descriptive statistics, including means, SDs, frequen-
cies and medians and IQRs, will be used, as appropriate.
Mean scores of continuous variables will be compared
between patients and their loved ones using paired
sample t tests or Wilcoxon signed rank tests, depending
on the variable distribution. Moreover, we will calculate
intraclass correlation coefﬁcients to study agreement
between patients and loved ones in mean scores and
visualise agreement using Bland and Altman plots.49
Cohen’s κ will be used to determine agreement in cat-
egorical variables. These analyses will be performed for
the COPM, CAT, mMRC, SF-12, IADLS and EQ-5D.
Furthermore, a mixed effect model will be used to esti-
mate longitudinal changes. Covariates such as age and
smoking status can be included as ﬁxed effects, whereas
time and exacerbation-related hospital admissions can
be entered as random effects. A priori, a two-sided level
of signiﬁcance will be set at p≤0.05.
Ethics and dissemination
This project will be conducted in accordance with the
declaration of Helsinki50 and the principles of the
Dutch Medical Research Involving Human Subjects Act
(‘WMO’).51
DISCUSSION
This study will focus on gaining knowledge about resi-
dent loved ones, including their role in the disease man-
agement and the interaction between the patient and
the resident loved one in their lifestyles. This informa-
tion is necessary to involve resident loved ones in the
disease management of patients with COPD. The study
has several strengths and limitations, which will be
described below.
Strengths
The approach of this study differs from other studies on
loved ones of patients with COPD, especially because of
the use of unique measurements and concepts. A major
strength of this study is the use of an individualised,
client-centred outcome to detect problems in ADLs
(COPM).28 A previous study included outcomes only
based on physical activity.52 The current study detects
problems in ADLs according to the patient and the
loved one using a semistructured interview method.
Additionally an accelerometer is used for both the
patient as well as for the loved one. Moreover, these
problematic ADLs are not only determined during base-
line and follow-up measurements, but also 2 weeks after
a COPD exacerbation-related hospital admission. The
changes in these ADL problems over time and after a
hospital admission are a unique point of view in this
population. Furthermore, in previous studies, character-
istics of the family or loved ones of the patients them-
selves were determined.17 53 54 In this study, not only
characteristics of the patients, and resident loved ones
are assessed, but also the resident loved ones’ percep-
tion of the patients’ characteristics (such as health
status, daily functioning and symptoms of anxiety and
depression). Further, capabilities of loved ones (like
coping styles and social support) will be investigated. In
addition, these measurements are not only performed
once, but will be repeated after a COPD exacerbation-
related hospital admission of the patient. Moreover, the
quality of the relationship between the patient and
resident loved one will be assessed. The quality of the
relationship could be one of the determinants of
the interaction between the resident loved one and the
patient. Therefore, this study provides a complete over-
view of the patient, the resident loved one, and the resi-
dent loved ones’ perceptions of the patient.
Other strengths of this study are related to the inclu-
sion of the participants. Many studies focus on male
patients with their female partners.14 18 53 In this study
an equal number of male and female participants will
be recruited and therefore the current study will also
provide knowledge concerning female patients and their
male resident loved ones. Furthermore, patients will also
be equally divided based on GOLD grading. Therefore,
this study includes the same number of patients with
moderate, severe and very severe COPD, which improves
the external validity of this study.
Moreover, the present study is a longitudinal study,
which makes it possible to analyse changes over time.
Finally, the tests and questionnaires will all be per-
formed at the patients’ home. So participant’s burden is
minimised and all data will be collected in their own
trusted environment.
Limitations
This study has some limitations. First, it may be possible
that patients and/or loved ones are not willing to partici-
pate. Although the burden of this study is minimised,
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a possible reason for refusing participation could be the
time investment. To minimise the burden of this
study, all measurements are performed in the patients’
homes and on a day and time of their preference.
Furthermore, the home visit can be spread over 2 days.
Nevertheless, it may be possible that most burdened
patients and loved ones are not willing to participate in
(additional) home visits. This could result in an under-
estimation of the burden, health status and well-being of
this population. Therefore, some characteristics of the
non-participating patients, like gender, age and GOLD
grade, will be collected. Furthermore, it may be possible
that participating resident loved ones are more aware of
the situation of the patient compared to the non-
participating loved ones. This should be taken into
account in interpreting the results. Second, it might be
challenging to include the same number of male and
female patients with COPD. However, collaboration with
four hospitals and recruitment of patients admitted to
the hospital as well as patients who attend the outpatient
clinic, will facilitate recruitment. Third, some loved ones
of admitted patients may be unwilling to participate in
additional home visits shortly after the patients’ admis-
sion to the hospital. This could lead to missing data or
even drop-outs. However, the time investment and
impact of this visit is minimal. Fourth, the follow-up
period is limited to 1 year. This follow-up period could
be too short to draw conclusions about long-term
changes in patients’ health status and problems during
ADLs and the perception of the resident loved ones
about these changes. Finally, it may be possible that par-
ticipation in this study works as a stimulus for patients to
talk about COPD with their loved ones. This could result
in more understanding and agreement during the mea-
surements after 12 months. However, if participants com-
municate more about the disease and the problems
during daily activities, the expectation is that this will be
performed shortly after the ﬁrst home visit.
Clinical consequences
The present study will gain more knowledge about the
resident loved ones of patients with COPD and about
their perceptions of the patients’ health status and prob-
lematic ADLs. With this information, a more systemic
approach in the treatment of patients with COPD could
be developed. Healthcare providers should not only
focus on the patient, but should see the patient, his/her
loved ones and their interaction as a whole. Only by
gaining more information about the loved ones them-
selves, the quality of the relationship, and their percep-
tion of the patients’ health status and problematic ADLs,
loved ones could be involved in the patient’s treatment.
With the knowledge gained in this study, we will learn
about how to carry out self-management plans in
patients and loved ones, so loved ones are able to facili-
tate and encourage the self-management. Furthermore,
this study investigates the impact of a hospitalisation due
to an acute COPD exacerbation on the resident loved
ones. With this information it may be possible to deter-
mine whether and how professional caregivers should
give more attention to the resident loved ones during an
exacerbation related hospitalisation.
CONCLUSION
In conclusion, COPD may have an impact on not only
the patients’ life, but also on the lives of the resident
loved ones. As a shift towards home care is anticipated,
the Home Sweet Home study is necessary to give more
insight in the home situation of patients with COPD.
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